As many as 69 trials trials, including 31 randomized controlled trials, have shown the effectiveness of ivermectin as a treatment for COVID-19. And 269 peer-review studies show the effectiveness of hydroxychloroquine.

A 2005 study indexed in the National Institutes of Health library found chloroquine, from which hydroxychloroquine is derived, had “strong antiviral effects” on SARS-CoV-1, which is about 90% the same as SARS-CoV-2, the virus that causes COVID-19.

Ivermectin, as WND reported, is featured on the NIH website as a treatment for COVID-19 that is “under evaluation.”

Dr. Paul Marik, a professor at Eastern Virginia Medical School, says it’s “completely outrageous” that the hospital in Norfolk where he serves as ICU director is telling physicians what they can prescribe and not prescribe, violating the doctor-patient relationship and the Hippocratic Oath.

Marik was a co-author of a peer-reviewed study published in February by the American Journal of Therapeutics that found that ivermectin reduces coronavirus infections, hospitalizations and deaths by about 75%.